Clinical Trials
19
Active:0
Completed:19
Trial Phases
2 Phases
Phase 1:18
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Phase 1
18 (94.7%)Phase 2
1 (5.3%)Bioavailability of Eszopiclone 3.0 mg With Regards to Reference Product
Phase 1
Completed
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2022-04-27
- Last Posted Date
- 2022-04-27
- Lead Sponsor
- Laboratorios Andromaco S.A.
- Target Recruit Count
- 28
- Registration Number
- NCT05349396
- Locations
- 🇮🇳
Azidus Laboratories Ltd., Chennai, Tamil Nadu, India
Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product
Phase 1
Completed
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2022-04-18
- Last Posted Date
- 2022-04-18
- Lead Sponsor
- Laboratorios Andromaco S.A.
- Target Recruit Count
- 10
- Registration Number
- NCT05332106
- Locations
- 🇮🇳
Azidus Laboratories Ltd., Chennai, Tamil Nadu, India
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
Phase 1
Completed
- Conditions
- Therapeutic Equivalency
- Interventions
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- Laboratorios Andromaco S.A.
- Target Recruit Count
- 36
- Registration Number
- NCT05282940
- Locations
- 🇮🇳
Azidus Laboratories Ltd., Chennai, Tamil Nadu, India
Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product
Phase 1
Completed
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Laboratorios Andromaco S.A.
- Target Recruit Count
- 44
- Registration Number
- NCT05250141
- Locations
- 🇮🇳
Azidus Laboratories Ltd., Chennai, Tamil Nadu, India
Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference Product
Phase 1
Completed
- Conditions
- Bioequivalence
- Interventions
- Drug: Diosmin/Hesperidin (90/10) 500 mg Test DrugDrug: Diosmin/Hesperidin (90/10) 500 mg Reference Product
- First Posted Date
- 2021-12-15
- Last Posted Date
- 2022-02-14
- Lead Sponsor
- Laboratorios Andromaco S.A.
- Target Recruit Count
- 12
- Registration Number
- NCT05158192
- Locations
- 🇮🇳
Azidus Laboratories Ltd., Chennai, Tamil Nadu, India
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found